Ageing and the telomere connection: An intimate relationship with inflammation

Ageing Research Reviews

Volumn 25, Issue , 2016, Pages 55-69

  Zhang, Jingwen ^a   Rane, Grishma ^a,b   Dai, Xiaoyun ^a   Shanmugam, Muthu K ^a   Arfuso, Frank ^c   Samy, Ramar Perumal ^a   Lai, Mitchell Kim Peng ^a,d   Kappei, Dennis ^b   Kumar, Alan Prem ^a,b,c,e,f   Sethi, Gautam ^a,c,d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c CURTIN UNIVERSITY   (Australia)

^d NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^e National University Cancer Institute   (Singapore)

^f UNIVERSITY OF NORTH TEXAS   (United States)

Author keywords

Ageing; Inflammation; Telomere

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; TELOMERASE;

AGING; CARDIOVASCULAR DISEASE; CELL AGING; CELL COMMUNICATION; CELL DEATH; CELL DIVISION; CHRONIC DISEASE; CYTOKINE RELEASE; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOPATHOLOGY; INFLAMMATION; INHERITANCE; METABOLIC DISORDER; MITOCHONDRIAL PERMEABILITY; NEOPLASM; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; REVIEW; SOMATIC CELL; TELOMERE; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING; ANIMAL; GENETICS; METABOLISM; PATHOLOGY;

AGING; ANIMALS; HUMANS; INFLAMMATION; TELOMERE;

EID: 84949200581     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2015.11.006     Document Type: Review

References (226)

1. Adaikalakoteswari A., Balasubramanyam M., Mohan V. Telomere shortening occurs in Asian Indian type 2 diabetic patients. Diabet. Med. 2005, 22:1151-1156.
2. Adler A.S., Sinha S., Kawahara T.L., Zhang J.Y., Segal E., Chang H.Y. Motif module map reveals enforcement of aging by continual NF-kappaB activity. Genes Dev. 2007, 21:3244-3257.
3. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging 2000, 21:383-421.
4. Akiyama M., Hideshima T., Hayashi T., Tai Y.T., Mitsiades C.S., Mitsiades N., Chauhan D., Richardson P., Munshi N.C., Anderson K.C. Nuclear factor-kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein. Cancer Res. 2003, 63:18-21.
5. Allsopp R.C., Vaziri H., Patterson C., Goldstein S., Younglai E.V., Futcher A.B., Greider C.W., Harley C.B. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:10114-10118.
6. Amsellem V., Gary-Bobo G., Marcos E., Maitre B., Chaar V., Validire P., Stern J.B., Noureddine H., Sapin E., Rideau D., Hue S., Le Corvoisier P., Le Gouvello S., Dubois-Rande J.L., Boczkowski J., Adnot S. Telomere dysfunction causes sustained inflammation in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2011, 184:1358-1366.
7. Andrews N.P., Fujii H., Goronzy J.J., Weyand C.M. Telomeres and immunological diseases of aging. Gerontology 2010, 56:390-403.
8. Arnoult N., Van Beneden A., Decottignies A. Telomere length regulates TERRA levels through increased trimethylation of telomeric H3K9 and HP1alpha. Nat. Struct. Mol. Biol. 2012, 19:948-956.
9. Arora R., Azzalin C.M. Telomere elongation chooses TERRA ALTernatives. RNA Biol. 2015, 12:938-941.
10. Arora R., Lee Y., Wischnewski H., Brun C.M., Schwarz T., Azzalin C.M. RNaseH1 regulates TERRA-telomeric DNA hybrids and telomere maintenance in ALT tumour cells. Nat. Commun. 2014, 5:5220.
11. Aubert G., Hills M., Lansdorp P.M. Telomere length measurement-caveats and a critical assessment of the available technologies and tools. Mutat. Res. 2012, 730:59-67.
12. Aubert G., Lansdorp P.M. Telomeres and aging. Physiol. Rev. 2008, 88:557-579.
13. Aviv A., Chen W., Gardner J.P., Kimura M., Brimacombe M., Cao X., Srinivasan S.R., Berenson G.S. Leukocyte telomere dynamics: longitudinal findings among young adults in the Bogalusa heart study. Am. J. Epidemiol. 2009, 169:323-329.
14. Azzalin C.M., Lingner J. Telomere functions grounding on TERRA firma. Trends Cell. Biol. 2015, 25:29-36.
15. Azzalin C.M., Reichenbach P., Khoriauli L., Giulotto E., Lingner J. Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. Science 2007, 318:798-801.
16. Babizhayev, M.A., Vishnyakova, K.S., Yegorov, Y.E., 2014. Oxidative damage impact on aging and age-related diseases: drug targeting of telomere attrition and dynamic telomerase activity flirting with imidazole-containing dipeptides. Recent patents on drug delivery & formulation 8, 163-192.
17. Baeuerle P.A., Baltimore D. NF-kappa B: ten years after. Cell 1996, 87:13-20.
18. Banning M. The principles of inflammation in the development of rheumatoid arthritis. Br. J. Nurs. 2005, 14:277-283.
19. Beier F., Balabanov S., Amberger C.C., Hartmann U., Manger K., Dietz K., Kotter I., Brummendorf T.H. Telomere length analysis in monocytes and lymphocytes from patients with systemic lupus erythematosus using multi-color flow-FISH. Lupus 2007, 16:955-962.
20. Bekaert S., De Meyer T., Rietzschel E.R., De Buyzere M.L., De Bacquer D., Langlois M., Segers P., Cooman L., Van Damme P., Cassiman P., Van Criekinge W., Verdonck P., De Backer G.G., Gillebert T.C., Van Oostveldt P. Telomere length and cardiovascular risk factors in a middle-aged population free of overt cardiovascular disease. Aging cell 2007, 6:639-647.
21. Bekaert S., Derradji H., Baatout S. Telomere biology in mammalian germ cells and during development. Dev. Biol. 2004, 274:15-30.
22. Bendix L., Kolvraa S. Telomeres and telomerase. Ugeskr. Laeger 2010, 172:2745-2748.
23. Bernardes de Jesus B., Schneeberger K., Vera E., Tejera A., Harley C.B., Blasco M.A. The telomerase activator TA-65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence. Aging cell 2011, 10:604-621.
24. Biroccio A., Cherfils-Vicini J., Augereau A., Pinte S., Bauwens S., Ye J., Simonet T., Horard B., Jamet K., Cervera L., Mendez-Bermudez A., Poncet D., Grataroli R., de Rodenbeeke C.T., Salvati E., Rizzo A., Zizza P., Ricoul M., Cognet C., Kuilman T., Duret H., Lepinasse F., Marvel J., Verhoeyen E., Cosset F.L., Peeper D., Smyth M.J., Londono-Vallejo A., Sabatier L., Picco V., Pages G., Scoazec J.Y., Stoppacciaro A., Leonetti C., Vivier E., Gilson E. TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells. Nat. Cell Biol. 2013, 15:818-828.
25. Blackburn E.H. Telomere states and cell fates. Nature 2000, 408:53-56.
26. Bodnar A.G., Kim N.W., Effros R.B., Chiu C.P. Mechanism of telomerase induction during T cell activation. Exp. Cell Res. 1996, 228:58-64.
27. Bonassi S., Abbondandolo A., Camurri L., Dal Pra L., De Ferrari M., Degrassi F., Forni A., Lamberti L., Lando C., Padovani P., et al. Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Preliminary results of an Italian cohort study. Cancer Genet. Cytogenet. 1995, 79:133-135.
28. Broer L., Codd V., Nyholt D.R., Deelen J., Mangino M., Willemsen G., Albrecht E., Amin N., Beekman M., de Geus E.J., Henders A., Nelson C.P., Steves C.J., Wright M.J., de Craen A.J., Isaacs A., Matthews M., Moayyeri A., Montgomery G.W., Oostra B.A., Vink J.M., Spector T.D., Slagboom P.E., Martin N.G., Samani N.J., van Duijn C.M., Boomsma D.I. Meta-analysis of telomere length in 19,713 subjects reveals high heritability, stronger maternal inheritance and a paternal age effect. Eur. J. Hum. Genet.: EJHG 2013, 21:1163-1168.
29. Bruunsgaard H., Pedersen B.K. Age-related inflammatory cytokines and disease. Immunol. Allergy Clin. North Am. 2003, 23:15-39.
30. Buchman A.R., Kimmerly W.J., Rine J., Kornberg R.D. Two DNA-binding factors recognize specific sequences at silencers, upstream activating sequences, autonomously replicating sequences, and telomeres in Saccharomyces cerevisiae. Mol. Cell Biol. 1988, 8:210-225.
31. Burns J.B., Lobo S.T., Bartholomew B.D. In vivo reduction of telomere length in human antigen-reactive memory T cells. Eur. J. Immunol. 2000, 30:1894-1901.
32. Campa D., Mergarten B., De Vivo I., Boutron-Ruault M.C., Racine A., Severi G., Nieters A., Katzke V.A., Trichopoulou A., Yiannakouris N., Trichopoulos D., Boeing H., Quiros J.R., Duell E.J., Molina-Montes E., Huerta J.M., Ardanaz E., Dorronsoro M., Khaw K.T., Wareham N., Travis R.C., Palli D., Pala V., Tumino R., Naccarati A., Panico S., Vineis P., Riboli E., Siddiq A., Bueno-de-Mesquita H.B., Peeters P.H., Nilsson P.M., Sund M., Ye W., Lund E., Jareid M., Weiderpass E., Duarte-Salles T., Kong S.Y., Stepien M., Canzian F., Kaaks R. Leukocyte telomere length in relation to pancreatic cancer risk: a prospective study. Cancer Epidemiology, Biomarkers & Prevention 2014, 23:2447-2454. A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
33. Campisi J., di Fagagna F.D. Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Bio. 2007, 8:729-740.
34. Carty C.L., Kooperberg C., Liu J., Herndon M., Assimes T., Hou L., Kroenke C.H., LaCroix A.Z., Kimura M., Aviv A., Reiner A.P. Leukocyte telomere length and risks of incident coronary heart disease and mortality in a racially diverse population of postmenopausal women. Arterioscler. Thromb. Vasc. Biol. 2015, 35:2225-2231.
35. Caruso C., Lio D., Cavallone L., Franceschi C. Aging, longevity, inflammation, and cancer. Ann. N. Y. Acad. Sci. 2004, 1028:1-13.
36. Celli G.B., de Lange T. DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion. Nat. Cell Biol. 2005, 7:712-718.
37. Cerne J.Z., Pohar-Perme M., Cerkovnik P., Gersak K., Novakovic S. Functional variants in CYP1B1, KRAS and MTHFR genes are associated with shorter telomere length in postmenopausal women. Mech. Ageing Dev. 2015, 149:1-7.
38. Chang M. Long telomeres: too much of a good thing. Biomol. Concepts 2012, 3:387-393.
39. Chiang Y.J., Kim S.H., Tessarollo L., Campisi J., Hodes R.J. Telomere-associated protein TIN2 is essential for early embryonic development through a telomerase-independent pathway. Mol. Cell Biol. 2004, 24:6631-6634.
40. Chiarugi A., Moskowitz M.A. Poly(ADP-ribose) polymerase-1 activity promotes NF-kappaB-driven transcription and microglial activation: implication for neurodegenerative disorders. J. Neurochem. 2003, 85:306-317.
41. Choi J., Fauce S.R., Effros R.B. Reduced telomerase activity in human T lymphocytes exposed to cortisol. Brain Behav. Immun. 2008, 22:600-605.
42. Chung H.Y., Sung B., Jung K.J., Zou Y., Yu B.P. The molecular inflammatory process in aging. Antioxid. Redox Signal. 2006, 8:572-581.
43. Colmegna I., Diaz-Borjon A., Fujii H., Schaefer L., Goronzy J.J., Weyand C.M. Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis. Arthritis Rheum. 2008, 58:990-1000.
44. Coppe J.P., Desprez P.Y., Krtolica A., Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 2010, 5:99-118.
45. Coppe J.P., Patil C.K., Rodier F., Sun Y., Munoz D.P., Goldstein J., Nelson P.S., Desprez P.Y., Campisi J. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008, 6:2853-2868.
46. Cusanelli E., Chartrand P. Telomeric repeat-containing RNA TERRA: a noncoding RNA connecting telomere biology to genome integrity. Front. Genet. 2015, 6(143).
47. d'Adda di Fagagna F., Reaper P.M., Clay-Farrace L., Fiegler H., Carr P., Von Zglinicki T., Saretzki G., Carter N.P., Jackson S.P. A DNA damage checkpoint response in telomere-initiated senescence. Nature 2003, 426:194-198.
48. Da-Silva N., Arasaradnam R., Getliffe K., Sung E., Oo Y., Nwokolo C. Altered mRNA expression of telomere binding proteins (TPP1 POT1, RAP1, TRF1 and TRF2) in ulcerative colitis and Crohn's disease. Dig. Liver Dis. 2010, 42:544-548.
49. Damjanovic A.K., Yang Y., Glaser R., Kiecolt-Glaser J.K., Nguyen H., Laskowski B., Zou Y., Beversdorf D.Q., Weng N.P. Accelerated telomere erosion is associated with a declining immune function of caregivers of Alzheimer's disease patients. J. Immunol. 2007, 179:4249-4254.
50. de Lange T. How telomeres solve the end-protection problem. Science 2009, 326:948-952.
51. De Meyer T., Rietzschel E.R., De Buyzere M.L., De Bacquer D., Van Criekinge W., De Backer G.G., Gillebert T.C., Van Oostveldt P., Bekaert S., Asklepios investors Paternal age at birth is an important determinant of offspring telomere length. Hum. Mol. Genet. 2007, 16:3097-3102.
52. Deeks S.G. HIV infection, inflammation, immunosenescence, and aging. Annu. Rev. Med. 2011, 62:141-155.
53. Denchi E.L., de Lange T. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature 2007, 448:1068-1071.
54. Deng Z., Glousker G., Molczan A., Fox A.J., Lamm N., Dheekollu J., Weizman O.E., Schertzer M., Wang Z., Vladimirova O., Schug J., Aker M., Londono-Vallejo A., Kaestner K.H., Lieberman P.M., Tzfati Y. Inherited mutations in the helicase RTEL1 cause telomere dysfunction and Hoyeraal-Hreidarsson syndrome. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:E3408-E3416.
55. Diala I., Wagner N., Magdinier F., Shkreli M., Sirakov M., Bauwens S., Schluth-Bolard C., Simonet T., Renault V.M., Ye J., Djerbi A., Pineau P., Choi J., Artandi S., Dejean A., Plateroti M., Gilson E. Telomere protection and TRF2 expression are enhanced by the canonical Wnt signalling pathway. EMBO Rep. 2013, 14:356-363.
56. Diehl M.C., Idowu M.O., Kimmelshue K.N., York T.P., Jackson-Cook C.K., Turner K.C., Holt S.E., Elmore L.W. Elevated TRF2 in advanced breast cancers with short telomeres. Breast Cancer Res. Treat. 2011, 127:623-630.
57. Ding H., Schertzer M., Wu X., Gertsenstein M., Selig S., Kammori M., Pourvali R., Poon S., Vulto I., Chavez E., Tam P.P., Nagy A., Lansdorp P.M. Regulation of murine telomere length by Rtel: an essential gene encoding a helicase like protein. Cell 2004, 117:873-886.
58. Dokal, I., 2011. Dyskeratosis congenita. Hematology/the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2011, 480-486.
59. Doksani Y., Wu J.Y., de Lange T., Zhuang X. Super-resolution fluorescence imaging of telomeres reveals TRF2-dependent T-loop formation. Cell 2013, 155:345-356.
60. Dorr J.R., Yu Y., Milanovic M., Beuster G., Zasada C., Dabritz J.H., Lisec J., Lenze D., Gerhardt A., Schleicher K., Kratzat S., Purfurst B., Walenta S., Mueller-Klieser W., Graler M., Hummel M., Keller U., Buck A.K., Dorken B., Willmitzer L., Reimann M., Kempa S., Lee S., Schmitt C.A. Synthetic lethal metabolic targeting of cellular senescence in cancer therapy. Nature 2013, 501:421-425.
61. Effros R.B., Allsopp R., Chiu C.P., Hausner M.A., Hirji K., Wang L., Harley C.B., Villeponteau B., West M.D., Giorgi J.V. Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS 1996, 10:F17-F22.
62. Effros R.B., Pawelec G. Replicative senescence of T cells: does the Hayflick Limit lead to immune exhaustion?. Immunol. Today 1997, 18:450-454.
63. Eitan E., Hutchison E.R., Mattson M.P. Telomere shortening in neurological disorders: an abundance of unanswered questions. Trends Neurosci. 2014, 37:256-263.
64. Eitan E., Tichon A., Gazit A., Gitler D., Slavin S., Priel E. Novel telomerase-increasing compound in mouse brain delays the onset of amyotrophic lateral sclerosis. EMBO Mol. Med. 2012, 4:313-329.
65. Entringer S., Epel E.S., Lin J., Buss C., Shahbaba B., Blackburn E.H., Simhan H.N., Wadhwa P.D. Maternal psychosocial stress during pregnancy is associated with newborn leukocyte telomere length. Am. J. Obstet. Gynecol. 2013, 208(134):e131-e137.
66. Epel E.S., Blackburn E.H., Lin J., Dhabhar F.S., Adler N.E., Morrow J.D., Cawthon R.M. Accelerated telomere shortening in response to life stress. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:17312-17315.
67. Fasth A.E., Bjorkstrom N.K., Anthoni M., Malmberg K.J., Malmstrom V. Activating NK-cell receptors co-stimulate CD4(+)CD28(-) T cells in patients with rheumatoid arthritis. Eur. J. Immunol. 2010, 40:378-387.
68. Fauce S.R., Jamieson B.D., Chin A.C., Mitsuyasu R.T., Parish S.T., Ng H.L., Kitchen C.M., Yang O.O., Harley C.B., Effros R.B. Telomerase-based pharmacologic enhancement of antiviral function of human CD8+ T lymphocytes. J. Immunol. 2008, 181:7400-7406.
69. Flynn R.L., Centore R.C., O'Sullivan R.J., Rai R., Tse A., Songyang Z., Chang S., Karlseder J., Zou L. TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch on telomeric single-stranded DNA. Nature 2011, 471:532-536.
70. Franceschi C., Bonafe M., Valensin S., Olivieri F., De Luca M., Ottaviani E., De Benedictis G. Inflamm-aging-an evolutionary perspective on immunosenescence. Ann. N.Y. Acad. Sci. 2000, 908:244-254.
71. Frenck R.W.J., Blackburn E.H., Shannon K.M. The rate of telomere sequence loss in human leukocytes varies with age. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:5607-5610.
72. Freund A., Orjalo A.V., Desprez P.Y., Campisi J. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol. Med. 2010, 16:238-246.
73. Fujii H., Shao L., Colmegna I., Goronzy J.J., Weyand C.M. Telomerase insufficiency in rheumatoid arthritis. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:4360-4365.
74. Fuster J.J., Zuriaga M.A., Ngo D.T., Farb M.G., Aprahamian T., Yamaguchi T.P., Gokce N., Walsh K. Noncanonical Wnt signaling promotes obesity-induced adipose tissue inflammation and metabolic dysfunction independent of adipose tissue expansion. Diabetes 2015, 64:1235-1248.
75. Gardner J.P., Li S., Srinivasan S.R., Chen W., Kimura M., Lu X., Berenson G.S., Aviv A. Rise in insulin resistance is associated with escalated telomere attrition. Circulation 2005, 111:2171-2177.
76. Gardner M., Bann D., Wiley L., Cooper R., Hardy R., Nitsch D., Martin-Ruiz C., Shiels P., Sayer A.A., Barbieri M., Bekaert S., Bischoff C., Brooks-Wilson A., Chen W., Cooper C., Christensen K., De Meyer T., Deary I., Der G., Diez Roux A., Fitzpatrick A., Hajat A., Halaschek-Wiener J., Harris S., Hunt S.C., Jagger C., Jeon H.S., Kaplan R., Kimura M., Lansdorp P., Li C., Maeda T., Mangino M., Nawrot T.S., Nilsson P., Nordfjall K., Paolisso G., Ren F., Riabowol K., Robertson T., Roos G., Staessen J.A., Spector T., Tang N., Unryn B., van der Harst P., Woo J., Xing C., Yadegarfar M.E., Park J.Y., Young N., Kuh D., von Zglinicki T., Ben-Shlomo Y., Halcyon study t. Gender and telomere length: systematic review and meta-analysis. Exp. Gerontol. 2014, 51:15-27.
77. George S.J. Wnt pathway: a new role in regulation of inflammation. Arterioscler. Thromb. Vasc. Biol. 2008, 28:400-402.
78. Ghosh A., Saginc G., Leow S.C., Khattar E., Shin E.M., Yan T.D., Wong M., Zhang Z., Li G., Sung W.K., Zhou J., Chng W.J., Li S., Liu E., Tergaonkar V. Telomerase directly regulates NF-kappaB-dependent transcription. Nat. Cell Biol. 2012, 14:1270-1281.
79. Graakjaer J., Bischoff C., Korsholm L., Holstebroe S., Vach W., Bohr V.A., Christensen K., Kolvraa S. The pattern of chromosome-specific variations in telomere length in humans is determined by inherited, telomere-near factors and is maintained throughout life. Mech. Ageing Dev. 2003, 124:629-640.
80. Green D.R., Galluzzi L., Kroemer G. Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science 2011, 333:1109-1112.
81. Griffith J.D., Comeau L., Rosenfield S., Stansel R.M., Bianchi A., Moss H., de Lange T. Mammalian telomeres end in a large duplex loop. Cell 1999, 97:503-514.
82. Haddad J.J. Science review: redox and oxygen-sensitive transcription factors in the regulation of oxidant-mediated lung injury: role for nuclear factor-kappaB. Crit. Care 2002, 6:481-490.
83. Hahn W.C., Weinberg R.A. Modelling the molecular circuitry of cancer. Nat. Rev. Cancer 2002, 2:331-341.
84. Hansen S., Baptiste K.E., Fjeldborg J., Horohov D.W. A review of the equine age-related changes in the immune system: comparisons between human and equine aging, with focus on lung-specific immune-aging. Ageing Res. Rev. 2015, 20C:11-23.
85. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345:458-460.
86. Harley C.B., Liu W., Blasco M., Vera E., Andrews W.H., Briggs L.A., Raffaele J.M. A natural product telomerase activator as part of a health maintenance program. Rejuvenation Res. 2011, 14:45-56.
87. Hayflick L. The future of ageing. Nature 2000, 408:267-269.
88. Hayflick L., Moorhead P.S. The serial cultivation of human diploid cell strains. Exp. Cell Res. 1961, 25:585-621.
89. Helenius M., Hanninen M., Lehtinen S.K., Salminen A. Aging-induced up-regulation of nuclear binding activities of oxidative stress responsive NF-kB transcription factor in mouse cardiac muscle. J. Mol. Cell Cardiol. 1996, 28:487-498.
90. Hemann M.T., Strong M.A., Hao L.Y., Greider C.W. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 2001, 107:67-77.
91. Herranz N., Gallage S., Mellone M., Wuestefeld T., Klotz S., Hanley C.J., Raguz S., Acosta J.C., Innes A.J., Banito A., Georgilis A., Montoya A., Wolter K., Dharmalingam G., Faull P., Carroll T., Martinez-Barbera J.P., Cutillas P., Reisinger F., Heikenwalder M., Miller R.A., Withers D., Zender L., Thomas G.J., Gil J. mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype. Nat. Cell Biol. 2015, 17:1205-1217.
92. Hochstrasser T., Marksteiner J., Humpel C. Telomere length is age-dependent and reduced in monocytes of Alzheimer patients. Exp. Gerontol. 2012, 47:160-163.
93. Hockemeyer D., Daniels J.P., Takai H., de Lange T. Recent expansion of the telomeric complex in rodents: two distinct POT1 proteins protect mouse telomeres. Cell 2006, 126:63-77.
94. Hofmann J.N., Lan Q., Cawthon R., Hosgood H.D., 3rd S., huch B., Moore L.E., Rothman N., Chow W.H., Purdue M.P. A prospective study of leukocyte telomere length and risk of renal cell carcinoma. Cancer Epidemiology, Biomarkers & Prevention 2013, 22:997-1000. A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
95. Hooijberg E., Ruizendaal J.J., Snijders P.J., Kueter E.W., Walboomers J.M., Spits H. Immortalization of human CD8+ T cell clones by ectopic expression of telomerase reverse transcriptase. J. Immunol. 2000, 165:4239-4245.
96. Horvath E.M., Szabo C. Poly(ADP-ribose) polymerase as a drug target for cardiovascular disease and cancer: an update. Drug News Perspect. 2007, 20:171-181.
97. Hsu C.P., Ko J.L., Shai S.E., Lee L.W. Modulation of telomere shelterin by TRF1 [corrected] and TRF2 interacts with telomerase to maintain the telomere length in non-small cell lung cancer. Lung Cancer 2007, 58:310-316.
98. Huzen J., de Boer R.A., van Veldhuisen D.J., van Gilst W.H., van der Harst P. The emerging role of telomere biology in cardiovascular disease. Front. Biosci. 2010, 15:35-45. (Landmark Ed.).
99. Igarashi H., Sakaguchi N. Telomerase activity is induced in human peripheral B lymphocytes by the stimulation to antigen receptor. Blood 1997, 89:1299-1307.
100. Iglesias-Bartolome R., Patel V., Cotrim A., Leelahavanichkul K., Molinolo A.A., Mitchell J.B., Gutkind J.S. mTOR inhibition prevents epithelial stem cell senescence and protects cositis. Cell Stem Cell 2012, 11:401-414.
101. Ip F.C., Ng Y.P., An H.J., Dai Y., Pang H.H., Hu Y.Q., Chin A.C., Harley C.B., Wong Y.H., Ip N.Y. Cycloastragenol is a potent telomerase activator in neuronal cells: implications for depression management. Neurosignals 2014, 22:52-63.
102. Jaskelioff M., Muller F.L., Paik J.H., Thomas E., Jiang S., Adams A.C., Sahin E., Kost-Alimova M., Protopopov A., Cadinanos J., Horner J.W., Maratos-Flier E., Depinho R.A. Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature 2011, 469:102-106.
103. Jurk D., Wilson C., Passos J.F., Oakley F., Correia-Melo C., Greaves L., Saretzki G., Fox C., Lawless C., Anderson R., Hewitt G., Pender S.L., Fullard N., Nelson G., Mann J., van de Sluis B., Mann D.A., von Zglinicki T. Chronic inflammation induces telomere dysfunction and accelerates ageing in mice. Nat. Commun. 2014, 2(4172).
104. Kabir S., Hockemeyer D., de Lange T. TALEN gene knockouts reveal no requirement for the conserved human shelterin protein Rap1 in telomere protection and length regulation. Cell Rep. 2014, 9:1273-1280.
105. Kananen L., Surakka I., Pirkola S., Suvisaari J., Lonnqvist J., Peltonen L., Ripatti S., Hovatta I. Childhood adversities are associated with shorter telomere length at adult age both in individuals with an anxiety disorder and controls. PLoS One 2010, 5:e10826.
106. Kappei D., Londono-Vallejo J.A. Telomere length inheritance and aging. Mech. Ageing Dev. 2008, 129:17-26.
107. Karlseder J., Hoke K., Mirzoeva O.K., Bakkenist C., Kastan M.B., Petrini J.H., de Lange T. The telomeric protein TRF2 binds the ATM kinase and can inhibit the ATM-dependent DNA damage response. PLoS Biol. 2004, 2:E240.
108. Karlseder J., Kachatrian L., Takai H., Mercer K., Hingorani S., Jacks T., de Lange T. Targeted deletion reveals an essential function for the telomere length regulator Trf1. Mol. Cell Biol. 2003, 23:6533-6541.
109. Kawanishi S., Oikawa S. Mechanism of telomere shortening by oxidative stress. Ann. N. Y. Acad. Sci. 2004, 1019:278-284.
110. Kelleher C., Kurth I., Lingner J. Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro. Mol. Cell Biol. 2005, 25:808-818.
111. Kibe T., Osawa G.A., Keegan C.E., de Lange T. Telomere protection by TPP1 is mediated by POT1a and POT1b. Mol. Cell Biol. 2010, 30:1059-1066.
112. Kim H.J., Jung K.J., Yu B.P., Cho C.G., Choi J.S., Chung H.Y. Modulation of redox-sensitive transcription factors by calorie restriction during aging. Mech. Ageing Dev. 2002, 123:1589-1595.
113. Kim H.J., Yu B.P., Chung H.Y. Molecular exploration of age-related NF-kappaB/IKK downregulation by calorie restriction in rat kidney. Free Radic. Biol. Med. 2002, 32:991-1005.
114. Knight S.W., Heiss N.S., Vulliamy T.J., Aalfs C.M., McMahon C., Richmond P., Jones A., Hennekam R.C., Poustka A., Mason P.J., Dokal I. Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1. Br. J. Haematol. 1999, 107:335-339.
115. Kolesnichenko M., Hong L., Liao R., Vogt P.K., Sun P. Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence. Cell Cycle 2012, 11:2391-2401.
116. Krishna B.H., Keerthi G.S., Kumar C.K., Reddy N.M. Association of leukocyte telomere length with oxidative stress in yoga practitioners. J. Clin. Diagn. Res. 2015, 9:CC01-03.
117. Kuilman T., Michaloglou C., Mooi W.J., Peeper D.S. The essence of senescence. Genes Dev. 2010, 24:2463-2479.
118. Kyo S., Takakura M., Kanaya T., Zhuo W., Fujimoto K., Nishio Y., Orimo A., Inoue M. Estrogen activates telomerase. Cancer Res. 1999, 59:5917-5921.
119. Laberge R.M., Sun Y., Orjalo A.V., Patil C.K., Freund A., Zhou L., Curran S.C., Davalos A.R., Wilson-Edell K.A., Liu S., Limbad C., Demaria M., Li P., Hubbard G.B., Ikeno Y., Javors M., Desprez P.Y., Benz C.C., Kapahi P., Nelson P.S., Campisi J. MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nat. Cell Biol. 2015, 17:1049-1061.
120. Lan Q., Cawthon R., Gao Y., Hu W., Hosgood H.D., 3rd Barone-Adesi, Ji F., Bassig B.T., Chow B., Shu W.H., Cai X., Xiang Q., Berndt Y., Kim S., Chanock C., Zheng S., Rothman W. Longer telomere length in peripheral white blood cells is associated with risk of lung cancer and the rs2736100 (CLPTM1L-TERT) polymorphism in a prospective cohort study among women in China. PLoS One 2013, 8:e59230.
121. Lee J., Jo Y.S., Sung Y.H., Hwang I.K., Kim H., Kim S.Y., Yi S.S., Choi J.S., Sun W., Seong J.K., Lee H.W. Telomerase deficiency affects normal brain functions in mice. Neurochem. Res. 2010, 35:211-218.
122. Lepez-Otin C., Blasco M.A., Partridge L., Serrano M., Kroemer G. The hallmarks of aging. Cell 2013, 153:1194-1217.
123. Liuzzo G., Goronzy J.J., Yang H., Kopecky S.L., Holmes D.R., Frye R.L., Weyand C.M. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 2000, 101:2883-2888.
124. Low K.C., Tergaonkar V. Telomerase: central regulator of all of the hallmarks of cancer. Trends Biochem. Sci. 2013, 38:426-434.
125. Ludlow A.T., Spangenburg E.E., Chin E.R., Cheng W.H., Roth S.M. Telomeres shorten in response to oxidative stress in mouse skeletal muscle fibers. J. Gerontol. A Biol. Sci. Med. Sci. 2014, 69:821-830.
126. Lynch S.M., Major J.M., Cawthon R., Weinstein S.J., Virtamo J., Lan Q., Rothman N., Albanes D., Stolzenberg-Solomon R.Z. A prospective analysis of telomere length and pancreatic cancer in the alpha-tocopherol beta-carotene cancer (ATBC) prevention study. Int. J. Cancer 2013, 133:2672-2680.
127. Ma H., Zhou Z., Wei S., Liu Z., Pooley K.A., Dunning A.M., Svenson U., Roos G., Hosgood H.D., Shen 3rd, Wei M. Shortened telomere length is associated with increased risk of cancer: a meta-analysis. PLoS One 2011, 6:e20466.
128. Maicher A., Lockhart A., Luke B. Breaking new ground: digging into TERRA function. Biochim. Biophys. Acta 2014, 1839:387-394.
129. Mangerich A., Burkle A. Pleiotropic cellular functions of PARP1 in longevity and aging: genome maintenance meets inflammation. Oxid. Med. Cell. Longev. 2012, 321653.
130. Marchetti B., Pluchino S. Wnt your brain be inflamed? Yes, it Wnt!. Trends Mol. Med. 2013, 19:144-156.
131. Marcon F., Siniscalchi E., Crebelli R., Saieva C., Sera F., Fortini P., Simonelli V., Palli D. Diet-related telomere shortening and chromosome stability. Mutagenesis 2012, 27:49-57.
132. Martens P.B., Goronzy J.J., Schaid D., Weyand C.M. Expansion of unusual CD4+ T cells in severe rheumatoid arthritis. Arthritis Rheum. 1997, 40:1106-1114.
133. Martinez P., Thanasoula M., Carlos A.R., Gomez-Lopez G., Tejera A.M., Schoeftner S., Dominguez O., Pisano D.G., Tarsounas M., Blasco M.A. Mammalian Rap1 controls telomere function and gene expression through binding to telomeric and extratelomeric sites. Nat. Cell Biol. 2010, 12:768-780.
134. Matsubara Y., Murata M., Yoshida T., Watanabe K., Saito I., Miyaki K., Omae K., Ikeda Y. Telomere length of normal leukocytes is affected by a functional polymorphism of hTERT. Biochem. Biophys. Res. Commun. 2006, 341:128-131.
135. Menzel O., Migliaccio M., Goldstein D.R., Dahoun S., Delorenzi M., Rufer N. Mechanisms regulating the proliferative potential of human CD8+ T lymphocytes overexpressing telomerase. J. Immunol. 2006, 177:3657-3668.
136. Migliaccio M., Amacker M., Just T., Reichenbach P., Valmori D., Cerottini J.C., Romero P., Nabholz M. Ectopic human telomerase catalytic subunit expression maintains telomere length but is not sufficient for CD8+ T lymphocyte immortalization. J. Immunol. 2000, 165:4978-4984.
137. Minghetti L. Role of inflammation in neurodegenerative diseases. Curr. Opin. Neurol. 2005, 18:315-321.
138. Moosig F., Csernok E., Wang G., Gross W.L. Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells. Clin. Exp. Immunol. 1998, 114:113-118.
139. Morgan R.G., Ives S.J., Lesniewski L.A., Cawthon R.M., Andtbacka R.H., Noyes R.D., Richardson R.S., Donato A.J. Age-related telomere uncapping is associated with cellular senescence and inflammation independent of telomere shortening in human arteries. Am. J. Physiol. Heart Circ. Physiol. 2013, 305:H251-H258.
140. Moverare-Skrtic S., Johansson P., Mattsson N., Hansson O., Wallin A., Johansson J.O., Zetterberg H., Blennow K., Svensson J. Leukocyte telomere length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer's disease: a pilot study. Exp. Gerontol. 2012, 47:179-182.
141. Nakajima T., Schulte S., Warrington K.J., Kopecky S.L., Frye R.L., Goronzy J.J., Weyand C.M. T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation 2002, 105:570-575.
142. Nandakumar J., Bell C.F., Weidenfeld I., Zaug A.J., Leinwand L.A., Cech T.R. The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity. Nature 2012, 492:285-289.
143. Narita M., Young A.R.J., Arakawa S., Samarajiwa S.A., Nakashima T., Yoshida S., Hong S.K., Berry L.S., Reichelt S., Ferreira M., Tavare S., Inoki K., Shimizu S., Narita M. Spatial coupling of mTOR and autophagy augments secretory phenotypes. Science 2011, 332:966-970.
144. Nawrot T.S., Staessen J.A., Holvoet P., Struijker-Boudier H.A., Schiffers P., Van Bortel L.M., Fagard R.H., Gardner J.P., Kimura M., Aviv A. Telomere length and its associations with oxidized-LDL, carotid artery distensibility and smoking. Front. Biosci. 2010, 2:1164-1168.
145. Nergadze S.G., Farnung B.O., Wischnewski H., Khoriauli L., Vitelli V., Chawla R., Giulotto E., Azzalin C.M. CpG-island promoters drive transcription of human telomeres. RNA 2009, 15:2186-2194.
146. Ning H., Li T., Zhao L., Li T., Li J., Liu J., Liu Z., Fan D. TRF2 promotes multidrug resistance in gastric cancer cells. Cancer Biol. Ther. 2006, 5:950-956.
147. Njajou O.T., Cawthon R.M., Damcott C.M., Wu S.H., Ott S., Garant M.J., Blackburn E.H., Mitchell B.D., Shuldiner A.R., Hsueh W.C. Telomere length is paternally inherited and is associated with parental lifespan. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:12135-12139.
148. Nordfjall K., Larefalk A., Lindgren P., Holmberg D., Roos G. Telomere length and heredity: indications of paternal inheritance. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:16374-16378.
149. Notaro R., Cimmino A., Tabarini D., Rotoli B., Luzzatto L. In vivo telomere dynamics of human hematopoietic stem cells. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:13782-13785.
150. Nzietchueng R., Elfarra M., Nloga J., Labat C., Carteaux J.P., Maureira P., Lacolley P., Villemot J.P., Benetos A. Telomere length in vascular tissues from patients with atherosclerotic disease. J. Nutr. Health Aging 2011, 15:153-156.
151. O'Donovan A., Pantell M.S., Puterman E., Dhabhar F.S., Blackburn E.H., Yaffe K., Cawthon R.M., Opresko P.L., Hsueh W.C., Satterfield S., Newman A.B., Ayonayon H.N., Rubin S.M., Harris T.B., Epel E.S. Cumulative inflammatory load is associated with short leukocyte telomere length in the health, aging and body composition study. PLoS One 2011, 6:e19687.
152. Ogami M., Ikura Y., Ohsawa M., Matsuo T., Kayo S., Yoshimi N., Hai E., Shirai N., Ehara S., Komatsu R., Naruko T., Ueda M. Telomere shortening in human coronary artery diseases. Arterioscler. Thromb. Vasc. Biol. 2004, 24:546-550.
153. Okuda K., Bardeguez A., Gardner J.P., Rodriguez P., Ganesh V., Kimura M., Skurnick J., Awad G., Aviv A. Telomere length in the newborn. Pediatr. Res. 2002, 52:377-381.
154. Olovnikov A.M. Principle of marginotomy in template synthesis of polynucleotides. Dokl. Akad. Nauk SSSR 1971, 201:1496-1499.
155. Opresko P.L., Fan J., Danzy S., Wilson D.M., 3rd B., ohr V.A. Oxidative damage in telomeric DNA disrupts recognition by TRF1 and TRF2. Nucl. Acids Res. 2005, 33:1230-1239.
156. Orjalo A.V., Bhaumik D., Gengler B.K., Scott G.K., Campisi J. Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:17031-17036.
157. Ortega-Molina A., Efeyan A., Lopez-Guadamillas E., Munoz-Martin M., Gomez-Lopez G., Canamero M., Mulero F., Pastor J., Martinez S., Romanos E., Mar Gonzalez-Barroso M., Rial E., Valverde A.M., Bischoff J.R., Serrano M. Pten positively regulates brown adipose function, energy expenditure, and longevity. Cell Metab. 2012, 15:382-394.
158. Palm W., de Lange T. How shelterin protects mammalian telomeres. Annu. Rev. Genet. 2008, 42:301-334.
159. Park H.H., Lee K.Y., Kim S., Lee J.W., Choi N.Y., Lee E.H., Lee Y.J., Lee S.H., Koh S.H. Novel vaccine peptide GV1001 effectively blocks beta-amyloid toxicity by mimicking the extra-telomeric functions of human telomerase reverse transcriptase. Neurobiol. Aging 2014, 35:1255-1274.
160. Park J.I., Venteicher A.S., Hong J.Y., Choi J., Jun S., Shkreli M., Chang W., Meng Z., Cheung P., Ji H., McLaughlin M., Veenstra T.D., Nusse R., McCrea P.D., Artandi S.E. Telomerase modulates Wnt signalling by association with target gene chromatin. Nature 2009, 460:66-72.
161. Paul L. Diet, nutrition and telomere length. J. Nutr. Biochem. 2011, 22:895-901.
162. Perry V.H., Cunningham C., Holmes C. Systemic infections and inflammation affect chronic neurodegeneration. Nat. Rev. Immunol. 2007, 7:161-167.
163. Plunkett F.J., Franzese O., Belaramani L.L., Fletcher J.M., Gilmour K.C., Sharifi R., Khan N., Hislop A.D., Cara A., Salmon M., Gaspar H.B., Rustin M.H., Webster D., Akbar A.N. The impact of telomere erosion on memory CD8+ T cells in patients with X-linked lymphoproliferative syndrome. Mech. Ageing Dev. 2005, 126:855-865.
164. Porro A., Feuerhahn S., Delafontaine J., Riethman H., Rougemont J., Lingner J. Functional characterization of the TERRA transcriptome at damaged telomeres. Nat. Commun. 2014, 5:5379.
165. Robin J.D., Ludlow A.T., Batten K., Magdinier F., Stadler G., Wagner K.R., Shay J.W., Wright W.E. Telomere position effect: regulation of gene expression with progressive telomere shortening over long distances. Genes Dev. 2014, 28:2464-2476.
166. Rodier F., Campisi J. Four faces of cellular senescence. J. Cell Biol. 2011, 192:547-556.
167. Roth A., Yssel H., Pene J., Chavez E.A., Schertzer M., Lansdorp P.M., Spits H., Luiten R.M. Telomerase levels control the lifespan of human T lymphocytes. Blood 2003, 102:849-857.
168. Rufer N., Brummendorf T.H., Dragowska V., Shultzer M., Wadsworth L.D., Lansdorp P.M. Turnover of stem cells, naive and memory T lymphocytes, estimated from telomere fluorescence measurements. Cytotherapy 1999, 1:342.
169. Rufer N., Brummendorf T.H., Kolvraa S., Bischoff C., Christensen K., Wadsworth L., Schulzer M., Lansdorp P.M. Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J. Exp. Med. 1999, 190:157-168.
170. Sahin E., Depinho R.A. Linking functional decline of telomeres, mitochondria and stem cells during ageing. Nature 2010, 464:520-528.
171. Salminen A., Kaarniranta K., Kauppinen A. Inflammaging: disturbed interplay between autophagy and inflammasomes. Aging-Us 2012, 4:166-175.
172. Samper E., Flores J.M., Blasco M.A. Restoration of telomerase activity rescues chromosomal instability and premature aging in Terc-/- mice with short telomeres. EMBO Rep. 2001, 2:800-807.
173. Sanders J.L., Newman A.B. Telomere length in epidemiology: a biomarker of aging, age-related disease, both, or neither?. Epidemiol. Rev. 2013.
174. Schoeftner S., Blasco M.A. Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II. Nat. Cell Biol. 2008, 10:228-236.
175. Schreck R., Albermann K., Baeuerle P.A. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic. Res. Commun. 1992, 17:221-237.
176. Schreurs M.W., Hermsen M.A., Geltink R.I., Scholten K.B., Brink A.A., Kueter E.W., Tijssen M., Meijer C.J., Ylstra B., Meijer G.A., Hooijberg E. Genomic stability and functional activity may be lost in telomerase-transduced human CD8+ T lymphocytes. Blood 2005, 106:2663-2670.
177. Schroder K., Hertzog P.J., Ravasi T., Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 2004, 75:163-189.
178. Sfeir A., Kabir S., van Overbeek M., Celli G.B., de Lange T. Loss of Rap1 induces telomere recombination in the absence of NHEJ or a DNA damage signal. Science 2010, 327:1657-1661.
179. Singh T., Newman A.B. Inflammatory markers in population studies of aging. Ageing Res. Rev. 2011, 10:319-329.
180. Slagboom P.E., Droog S., Boomsma D.I. Genetic determination of telomere size in humans: a twin study of three age groups. Am. J. Hum. Genet. 1994, 55:876-882.
181. Son N.H., Joyce B., Hieatt A., Chrest F.J., Yanovski J., Weng N.P. Stable telomere length and telomerase expression from naive to memory B-lymphocyte differentiation. Mech. Ageing Dev. 2003, 124:427-432.
182. Son N.H., Murray S., Yanovski J., Hodes R.J., Weng N. Lineage-specific telomere shortening and unaltered capacity for telomerase expression in human T and B lymphocytes with age. J. Immunol. 2000, 165:1191-1196.
183. Stansel R.M., de Lange T., Griffith J.D. T-loop assembly in vitro involves binding of TRF2 near the 3' telomeric overhang. EMBO J. 2001, 20:5532-5540.
184. Starr J.M., Shiels P.G., Harris S.E., Pattie A., Pearce M.S., Relton C.L., Deary I.J. Oxidative stress, telomere length and biomarkers of physical aging in a cohort aged 79 years from the 1932 Scottish mental survey. Mech. Ageing Dev. 2008, 129:745-751.
185. Sun L., Tan R., Xu J., LaFace J., Gao Y., Xiao Y., Attar M., Neumann C., Li G.M., Su B., Liu Y., Nakajima S., Levine A.S., Lan L. Targeted DNA damage at individual telomeres disrupts their integrity and triggers cell death. Nucl. Acids Res. 2015.
186. Takai H., Smogorzewska A., de Lange T. DNA damage foci at dysfunctional telomeres. Curr. Biol.: CB 2003, 13:1549-1556.
187. Takata Y., Kikukawa M., Hanyu H., Koyama S., Shimizu S., Umahara T., Sakurai H., Iwamoto T., Ohyashiki K., Ohyashiki J.H. Association between ApoE phenotypes and telomere erosion in Alzheimer's disease. J. Gerontol. A Biol. Sci. Med. Sci. 2012, 67:330-335.
188. Tarhan F., Vural F., Kosova B., Aksu K., Cogulu O., Keser G., Gunduz C., Tombuloglu M., Oder G., Karaca E., Doganavsargil E. Telomerase activity in connective tissue diseases: elevated in rheumatoid arthritis, but markedly decreased in systemic sclerosis. Rheumatol. Int. 2008, 28:579-583.
189. Teo H., Ghosh S., Luesch H., Ghosh A., Wong E.T., Malik N., Orth A., de Jesus P., Perry A.S., Oliver J.D., Tran N.L., Speiser L.J., Wong M., Saez E., Schultz P., Chanda S.K., Verma I.M., Tergaonkar V. Telomere-independent Rap1 is an IKK adaptor and regulates NF-kappaB-dependent gene expression. Nat. Cell Biol. 2010, 12:758-767.
190. Tilstra J.S., Robinson A.R., Wang J., Gregg S.Q., Clauson C.L., Reay D.P., Nasto L.A., St Croix C.M., Usas A., Vo N., Huard J., Clemens P.R., Stolz D.B., Guttridge D.C., Watkins S.C., Garinis G.A., Wang Y.S., Niedernhofer L.J., Robbins P.D. NF-kappa B inhibition delays DNA damage-induced senescence and aging in mice. J. Clin. Invest. 2012, 122:2601-2612.
191. Townsley D.M., Dumitriu B., Young N.S. Bone marrow failure and the telomeropathies. Blood 2014, 124:2775-2783.
192. Tracy R.P. Emerging relationships of inflammation, cardiovascular disease and chronic diseases of aging. Int. J. Obes. Relat. Metab. Disord. 2003, 27(Suppl. 3):S29-S34.
193. Traila D., Mladinescu O.F., Oancea C., Tudorache V. Short telomeres in pulmonary fibrosis: from genetics to clinical significance. Pneumologia 2015, 64(8):11-13.
194. Tyrka A.R., Price L.H., Kao H.T., Porton B., Marsella S.A., Carpenter L.L. Childhood maltreatment and telomere shortening: preliminary support for an effect of early stress on cellular aging. Biol. Psychiatry 2010, 67:531-534.
195. Ungar L., Harari Y., Toren A., Kupiec M. Tor complex 1 controls telomere length by affecting the level of Ku. Curr. Biol.: CB 2011, 21:2115-2120.
196. Valdes A.M., Andrew T., Gardner J.P., Kimura M., Oelsner E., Cherkas L.F., Aviv A., Spector T.D. Obesity, cigarette smoking, and telomere length in women. Lancet 2005, 366:662-664.
197. Valenzuela H.F., Effros R.B. Divergent telomerase and CD28 expression patterns in human CD4 and CD8T cells following repeated encounters with the same antigenic stimulus. Clin. Immunol. 2002, 105:117-125.
198. Vannier J.B., Sarek G., Boulton S.J. RTEL1: functions of a disease-associated helicase. Trends Cell. Biol. 2014, 24:416-425.
199. Vina J., Borras C., Gambini J., Sastre J., Pallardo F.V. Why females live longer than males? Importance of the upregulation of longevity-associated genes by oestrogenic compounds. FEBS Lett. 2005, 579:2541-2545.
200. von Zglinicki T. Role of oxidative stress in telomere length regulation and replicative senescence. Ann. N. Y. Acad. Sci. 2000, 908:99-110.
201. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem. Sci. 2002, 27:339-344.
202. Wallace D.C., Fan W., Procaccio V. Mitochondrial energetics and therapeutics. Annu. Rev. Pathol. 2010, 5:297-348.
203. Wallace D.L., Berard M., Soares M.V., Oldham J., Cook J.E., Akbar A.N., Tough D.F., Beverley P.C. Prolonged exposure of naive CD8+ T cells to interleukin-7 or interleukin-15 stimulates proliferation without differentiation or loss of telomere length. Immunology 2006, 119:243-253.
204. Wang C., Meier U.T. Architecture and assembly of mammalian H/ACA small nucleolar and telomerase ribonucleoproteins. EMBO J. 2004, 23:1857-1867.
205. Wang F., Podell E.R., Zaug A.J., Yang Y., Baciu P., Cech T.R., Lei M. The POT1-TPP1 telomere complex is a telomerase processivity factor. Nature 2007, 445:506-510.
206. Wang K., Klionsky D.J. Mitochondria removal by autophagy. Autophagy 2011, 7:297-300.
207. Wang Z., Rhee D.B., Lu J., Bohr C.T., Zhou F., Vallabhaneni H., de Souza-Pinto N.C., Liu Y. Characterization of oxidative guanine damage and repair in mammalian telomeres. PLoS Genet. 2010, 6:e1000951.
208. Watson J.D. Origin of concatemeric T7 DNA. Nat.: New Biol. 1972, 239:197-201.
209. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112:1796-1808.
210. Weng N.P. Regulation of telomerase expression in human lymphocytes. Springer Semin. Immunopathol. 2002, 24:23-33.
211. Weng N.P. Telomere and adaptive immunity. Mech. Ageing Dev. 2008, 129:60-66.
212. Weng N.P., Granger L., Hodes R.J. Telomere lengthening and telomerase activation during human B cell differentiation. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:10827-10832.
213. Weng N.P., Palmer L.D., Levine B.L., Lane H.C., June C.H., Hodes R.J. Tales of tails: regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging. Immunol. Rev. 1997, 160:43-54.
214. Weyand C.M., Fujii H., Shao L., Goronzy J.J. Rejuvenating the immune system in rheumatoid arthritis. Nat. Rev. Rheumatol. 2009, 5:583-588.
215. Wikgren M., Karlsson T., Nilbrink T., Nordfjall K., Hultdin J., Sleegers K., Van Broeckhoven C., Nyberg L., Roos G., Nilsson L.G., Adolfsson R., Norrback K.F. APOE epsilon4 is associated with longer telomeres, and longer telomeres among epsilon4 carriers predicts worse episodic memory. Neurobiol. Aging 2012, 33:335-344.
216. Wu P., Takai H., de Lange T. Telomeric 3' overhangs derive from resection by Exo1 and Apollo and fill-in by POT1b-associated CST. Cell 2012, 150:39-52.
217. Xin Z.T., Beauchamp A.D., Calado R.T., Bradford J.W., Regal J.A., Shenoy A., Liang Y., Lansdorp P.M., Young N.S., Ly H. Functional characterization of natural telomerase mutations found in patients with hematologic disorders. Blood 2007, 109:524-532.
218. Yamaguchi H., Calado R.T., Ly H., Kajigaya S., Baerlocher G.M., Chanock S.J., Lansdorp P.M., Young N.S. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N. Eng. J. Med. 2005, 352:1413-1424.
219. Yang Z., Huang X., Jiang H., Zhang Y., Liu H., Qin C., Eisner G.M., Jose P.A., Rudolph L., Ju Z. Short telomeres and prognosis of hypertension in a chinese population. Hypertension 2009, 53:639-645.
220. You X.J., Bryant P.J., Jurnak F., Holcombe R.F. Expression of Wnt pathway components frizzled and disheveled in colon cancer arising in patients with inflammatory bowel disease. Oncol. Rep. 2007, 18:691-694.
221. Young A.R., Narita M. SASP reflects senescence. EMBO Rep. 2009, 10:228-230.
222. Zhang C., Chen X., Li L., Zhou Y., Wang C., Hou S. The association between telomere length and cancer prognosis: evidence from a meta-analysis. PLoS One 2015, 10:e0133174.
223. Zhang C., Doherty J.A., Burgess S., Hung R.J., Lindstrom S., Kraft P., Gong J., Amos C.I., Sellers T.A., Monteiro A.N., Chenevix-Trench G., Bickeboller H., Risch A., Brennan P., McKay J.D., Houlston R.S., Landi M.T., Timofeeva M.N., Wang Y., Heinrich J., Kote-Jarai Z., Eeles R.A., Muir K., Wiklund F., Gronberg H., Berndt S.I., Chanock S.J., Schumacher F., Haiman C.A., Henderson B.E., Amin Al Olama A., Andrulis I.L., Hopper J.L., Chang-Claude J., John E.M., Malone K.E., Gammon M.D., Ursin G., Whittemore A.S., Hunter D.J., Gruber S.B., Knight J.A., Hou L., Le Marchand L., Newcomb P.A., Hudson T.J., Chan A.T., Li L., Woods M.O., Ahsan H., Pierce B.L., Gecco and Game-On Network: Corect, D.E.F., Tricl Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study. Hum. Mol. Genet. 2015, 24:5356-5366.
224. Zhang G., Li J., Purkayastha S., Tang Y., Zhang H., Yin Y., Li B., Liu G., Cai D. Hypothalamic programming of systemic ageing involving IKK-beta, NF-kappaB and GnRH. Nature 2013, 497:211-216.
225. Zhou J.G., Qing Y.F., Yang Q.B., Xie W.G., Zhao M.C. Changes in the expression of telomere maintenance genes might play a role in the pathogenesis of systemic lupus erythematosus. Lupus 2011, 20:820-828.
226. Zhou R., Yazdi A.S., Menu P., Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011, 469:221-225.